Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

High-dose IV ascorbic acid therapy in CCUS patients with TET2 mutations

Zhuoer Xie, Jenna Fernandez, Terra L Lasho, Christy M. Finke, Michelle Amundson, Kristen McCullough, Betsy LaPlant, Abhishek A Mangaonkar, Naseema Gangat, Kaaren K Reichard, Michelle Ann Elliott, Thomas E. Witzig, Mrinal M. Patnaik

Blood blood.2024024962.

https://doi.org/10.1182/blood.2024024962

Published: 2024

Includes: Supplemental data

Journal Articles

Genetic Complementation Studies Reveal That Many Disease-Associated DDX41 Variants Do Not Cause Loss of Protein Function

Timothy Chlon, Emily Stepanchick, Christy M Finke, Terra L Lasho, Talha Badar, Alejandro Ferrer, Mrinal M. Patnaik

Blood (2023) 142 (Supplement 1): 4104.

https://doi.org/10.1182/blood-2023-181881

Published: 2023

Journal Articles

Targeting Oncogenic Enhancers in ASXL1 -Mutant Chronic Myelomonocytic Leukemia

Terra L Lasho, Christy M Finke, Jenna A. Fernandez, Christopher T. Schmitz, Karl J. Clark, Claes Wahlestedt, Judy Chiao, Abhishek A Mangaonkar, Mrinal M. Patnaik, Moritz Binder

Blood (2023) 142 (Supplement 1): 1413.

https://doi.org/10.1182/blood-2023-178083

Published: 2023

Journal Articles

ASXL1 / TET2 Genotype-Based Risk Stratification Outperforms ASXL1 Mutational Impact and Is Independent of Mutant Variant Allele Fractions (VAF) in CMML

Clifford M Csizmar, Mark Gurney, Rashmi Kanagal-Shamanna, Kelly S. Chien, Danielle E. Hammond, Terra L Lasho, Christy M Finke, Christopher Dean, Abhishek A Mangaonkar, Naseema Gangat, Ayalew Tefferi, Hassan Alkhateeb, Guillermo Garcia-Manero, Guillermo Montalban-Bravo, Mrinal M. Patnaik

Blood (2023) 142 (Supplement 1): 4615.

https://doi.org/10.1182/blood-2023-187235

Published: 2023

Journal Articles

Clinical and Molecular Spectrum of Somatic Mosaic States in DDX41 mutant Germline Predisposition Syndromes

Talha Badar, Terra L Lasho, Yael Kusne, Ludovica Marando, Abhishek A Mangaonkar, Christy M Finke, James M. Foran, Aref Al-Kali, Hassan Alkhateeb, Naseema Gangat, Rong He, David Viswanatha, Mark R. Litzow, Timothy Chlon, Alejandro Ferrer, Mrinal M. Patnaik

Blood (2023) 142 (Supplement 1): 4618.

https://doi.org/10.1182/blood-2023-187310

Published: 2023

Journal Articles

Distribution of Chromosome-Arm Specific Telomere Length in Patients with Telomere Biology Disorders

Alejandro Ferrer, Zachary D Stephens, Susan M. Geyer, Rachel A Simon, Terra L Lasho, Christy M Finke, Brittany Burnap, Lindsay A Mulvihill, Tammy M McAllister, Carolyn R. Rohrer Vitek, Konstantinos N Lazaridis, Angita Jain, Eric W Klee, Jean-Pierre A Kocher, Mrinal M. Patnaik

Blood (2023) 142 (Supplement 1): 4103.

https://doi.org/10.1182/blood-2023-187486

Published: 2023

Journal Articles

Phase II Study Assessing Safety and Preliminary Efficacy of High Dose Intravenous Ascorbic Acid in Patients with TET2 Mutant Clonal Cytopenias

Zhuoer Xie, Kristen McCullough, Terra L Lasho, Jenna A. Fernandez, Christy M Finke, Michelle Renee Amundson, Betsy LaPlant, Abhishek Mangaokar, Naseema Gangat, Kaaren K. Reichard, Michelle Ann Elliott, Thomas E. Witzig, Mrinal M. Patnaik

Blood (2023) 142 (Supplement 1): 4611.

https://doi.org/10.1182/blood-2023-186595

Published: 2023

Journal Articles

Prognostic Relevance of Truncating ASXL1 Mutations and ASXL1 -Integrated Molecular Models in Proliferative CMML

Clifford M Csizmar, Mark Gurney, Terra L Lasho, Rashmi Kanagal-Shamanna, Kelly S. Chien, Danielle E. Hammond, Christy M Finke, Abhishek A Mangaonkar, Aref Al-Kali, Naseema Gangat, Ayalew Tefferi, Hassan Alkhateeb, Guillermo Garcia-Manero, Guillermo Montalban-Bravo, Mrinal M. Patnaik

Blood (2023) 142 (Supplement 1): 3241.

https://doi.org/10.1182/blood-2023-186881

Published: 2023

Journal Articles

Functional Testing of Variants of Uncertain Significance in TERC, TERT ,and RTEL1 from Adult Patients with Telomere Biology Disorders

Rachel A Simon, Christy M Finke, Terra L Lasho, Christopher T. Schmitz, Jenna A Fernandez, Eva M Carmona-Porquera, Mark E Wylam, Thomas E. Witzig, Tammy M McAllister, Carolyn R. Rohrer Vitek, Konstantinos N Lazaridis, Abhishek A Mangaonkar, Mrinal M. Patnaik, Alejandro Ferrer

Blood (2023) 142 (Supplement 1): 1365.

https://doi.org/10.1182/blood-2023-190153

Published: 2023

Journal Articles

Cellular Interactions within Clonal Dendritic Cell Aggregates Drive Immune Tolerance in Chronic Myelomonocytic Leukemia Bone Marrow Microenvironment

Abhishek A Mangaonkar, Terra L Lasho, Justin Boysen, Christy M Finke, Jenna A. Fernandez, Jose. C. Villasboas, Christopher Dean, Alejandro Ferrer, Moritz Binder, Liguo Wang, Jeong-Heon Lee, Kaaren K. Reichard, Mrinal M. Patnaik

Blood (2023) 142 (Supplement 1): 4077.

https://doi.org/10.1182/blood-2023-186856

Published: 2023

Journal Articles

The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants

Ayalew Tefferi, Terra L. Lasho, Alexander Tischer, Emnet A. Wassie, Christy M. Finke, Alem A. Belachew, Rhett P. Ketterling, Curtis A. Hanson, Animesh D. Pardanani

Blood (2014) 124 (15): 2465–2466.

https://doi.org/10.1182/blood-2014-07-588426

Published: 2014

Includes: Supplemental data

Journal Articles

SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survival

Terra L. Lasho, Thitina Jimma, Christy M. Finke, Mrinal Patnaik, Curtis A. Hanson, Rhett P. Ketterling, Animesh Pardanani, Ayalew Tefferi

Blood (2012) 120 (20): 4168–4171.

https://doi.org/10.1182/blood-2012-05-429696

Published: 2012

Includes: Supplemental data

Journal Articles

WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adults

Animesh Pardanani, Ken-Hong Lim, Terra L. Lasho, Christy M. Finke, Rebecca F. McClure, Chin-yang Li, Ayalew Tefferi

Blood (2010) 115 (1): 150–151.

https://doi.org/10.1182/blood-2009-10-249979

Published: 2010

Journal Articles

Oligonucleotide Array CGH Studies in Myeloproliferative Neoplasms and Comparison with Conventional Cytogenetic Analysis

Ayalew Tefferi, MD, Shireen Sirhan, MD, Yi Sun, PhD, Terra L. Lasho, MT(ASCP), Charles A. LeDuc, PhD, Christy M. Finke, James Weisberger, MD, Sherri Bale, PhD, John Compton, PhD, Animesh Pardanani, MD, PhD, Erik C. Thorland, PhD, Yuriy Shevchenko, PhD, Marc D. Grodman, MD, Wendy K. Chung, MD, PhD

Blood (2007) 110 (11): 1550.

https://doi.org/10.1182/blood.V110.11.1550.1550

Published: 2007

Journal Articles

Cytogenetic Studies at Diagnosis in Polycythemia Vera: Clinical and JAK2 V617F Allele Burden Correlates.

Naseema Gangat, MD, Jacob J. Strand, Terra L. Lasho, MT(ASCP), Christy M. Finke, Ryan A. Knudson, Animesh Pardanani, MD, PhD, Chin-Yang Li, MD, Rhett P. Ketterling, MD, Ayalew Tefferi, MD

Blood (2007) 110 (11): 2545.

https://doi.org/10.1182/blood.V110.11.2545.2545

Published: 2007

Journal Articles

A Local Versus Centralized Processing Comparison of Plasma Cell Isolation, Viability, and RNA Integrity.

Gregory J. Ahmann, Kimberly J. Henderson, Tammy L. Price-Troska, Michael M. Timm, Rempel Rachel, Roberta W. DeGoey, Christy M. Finke, Angela Dispenzieri, Philip R. Greipp, Alicia Sable-Hunt, Leif Bergsagel, Rafael Fonseca

Blood (2005) 106 (11): 3413.

https://doi.org/10.1182/blood.V106.11.3413.3413

Published: 2005

NARROW

High-dose IV ascorbic acid therapy in CCUS patients with TET2 mutations

Genetic Complementation Studies Reveal That Many Disease-Associated DDX41 Variants Do Not Cause Loss of Protein Function

Targeting Oncogenic Enhancers in ASXL1 -Mutant Chronic Myelomonocytic Leukemia

ASXL1 / TET2 Genotype-Based Risk Stratification Outperforms ASXL1 Mutational Impact and Is Independent of Mutant Variant Allele Fractions (VAF) in CMML

Clinical and Molecular Spectrum of Somatic Mosaic States in DDX41 mutant Germline Predisposition Syndromes

Distribution of Chromosome-Arm Specific Telomere Length in Patients with Telomere Biology Disorders

Phase II Study Assessing Safety and Preliminary Efficacy of High Dose Intravenous Ascorbic Acid in Patients with TET2 Mutant Clonal Cytopenias

Prognostic Relevance of Truncating ASXL1 Mutations and ASXL1 -Integrated Molecular Models in Proliferative CMML

Functional Testing of Variants of Uncertain Significance in TERC, TERT ,and RTEL1 from Adult Patients with Telomere Biology Disorders

Cellular Interactions within Clonal Dendritic Cell Aggregates Drive Immune Tolerance in Chronic Myelomonocytic Leukemia Bone Marrow Microenvironment

The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants

SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survival

WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adults

Oligonucleotide Array CGH Studies in Myeloproliferative Neoplasms and Comparison with Conventional Cytogenetic Analysis

Cytogenetic Studies at Diagnosis in Polycythemia Vera: Clinical and JAK2 V617F Allele Burden Correlates.

A Local Versus Centralized Processing Comparison of Plasma Cell Isolation, Viability, and RNA Integrity.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only